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Introduction: Laparoscopic liver resection can either be total laparoscopic or hand-assisted laparoscopic
approach. The recent introduction of robotic surgical systems has revolutionized the ﬁeld of minimally
invasive surgery. It was developed to overcome the disadvantages of conventional laparoscopic surgery.
The role of robotic system in laparoscopic surgery was not well evaluated yet. The aim of this cohort
study was to evaluate the outcome of multimodality approach of laparoscopic liver resection for hepatic
malignancy
Methods: From January 1998 to August 2010, all patients with hepatic malignancy underwent laparo-
scopic liver resection were included. A prospectively collected data was analyzed retrospectively.
Results: During the studyperiod, a total of 56patientswithhepaticmalignancies (hepatocellular carcinoma,
HCC, n¼ 42; colorectal livermetastases, CLM, n¼ 14) underwent laparoscopic liver resection in our surgical
unit. Themajority of caseswere performed by hand-assisted laparoscopic approach, n¼ 31 (55.3%) and the
remainderwerewith total laparoscopic approach, n¼ 10 (17.9%) and robot-assisted laparoscopic approach,
n¼ 15 (26.8%). Themedian operation timewas 150min (range, 75e307min). Themedian blood loss during
surgerywas175ml (range, 5e2000ml). Twopatients (3.6%) neededopen conversion andonepatient (1.8%)
needed to be converted to hand-assisted laparoscopic approach. The morbidity rate was 14.3%. There was
no procedure-related death. 89.3% of patients had R0 resection and 10.7% of patients had R1 resection. The
median hospital stay was 6.5 days (range, 2e13 days).
The 1-year, 3-year, and 5-year disease-free survival rates for HCC were 85%, 47%, and 38%, respectively.
The 1-year, 3-year, and 5-year overall survival rates for HCC were 96%, 67%, and 52%, respectively. The
1-year, and 3-year disease-free survival rates for CLM were 92% and 72%. The 1-year, and 3-year overall
survival rates for CLM were 100% and 88%, respectively.
Conclusions: Multimodality approach of laparoscopic liver resection of hepatic malignancy was feasible,
and safe in selected patients. It was associated with a low complications rate. The mid-term and long-
term survival outcome was favorable also.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The development of minimally invasive surgery over the last
two decades has a great impact on the surgical practice. Laparo-
scopic liver resection also becomes possible with the availability of
new instruments that allow a relatively bloodless liver transection.
The advantages of laparoscopic liver resection are those of mini-
mally invasive surgery, such as early recovery, shorter hospital stay,
and better cosmetic outcome.1 The post-operative course after
laparoscopic liver resection may also be improved in patients with
cirrhosis because the abdominal wall is preserved, kinetics of thefax: þ86 852 2515 3195.
. Lai).
ciates Ltd. Published by Elsevier Ltdiaphragm are improved, collateral venous drainage is better and
there is less post-operative ascites. However, the role of laparo-
scopic liver resection for hepatic malignancy is still unclear because
of the uncertainty of the long-term results, and the fear of
compromising the oncological resection. Available long-term
survival data about laparoscopic liver resection for hepatic malig-
nancy in the literature are limited still.2e8
Traditionally, laparoscopic liver resection can either be total
laparoscopic or hand-assisted laparoscopic approach.1 Techniques
of hand-assisted laparoscopic has been attempted to bridge the gap
between open and conventional total laparoscopic approach. The
recent introduction of robotic surgical systems has revolutionized
the ﬁeld of minimally invasive surgery.9 It was developed to over-
come the disadvantages of conventional laparoscopic surgery.d. All rights reserved.
Table 1
Characteristics of the 42 patients with HCC.
Sex ratio (M:F) 31:11
Age [mean  SD] 58.2  10.4
Liver status
Liver cirrhosis (n) 40
Non-cirrhotic liver (n) 2
Hepatitis status
Hepatitis B carrier (n) 39
Hepatitis C carrier (n) 2
Recurrent HCC 3
Preoperative liver function of
cirrhotic liver
Pugh’s modiﬁcation of Child’s grade A 40
E.C.H. Lai et al. / International Journal of Surgery 9 (2011) 324e328 325
ORIGINAL RESEARCHHowever, the role of robotic system in laparoscopic surgery was not
well evaluated yet.
The aim of the present cohort study was to evaluate the clinical
outcome of multimodality approach of laparoscopic liver resection
for hepatic malignancy.
2. Materials and methods
A prospective data collection of laparoscopic liver resection was initiated in our
surgical center in 1998. The study population was a consecutive series of patients
with hepatic malignancy who underwent conventional total laparoscopic liver
resection, hand-assisted laparoscopic liver resection or robot-assisted laparoscopic
liver resection in a tertiary referral center from January 1998 to August 2010. Robotic
surgery was started in May 2009 in our hospital. Our programme of robot-assisted
laparoscopic liver resectionwas started in June 2009. During the study period, a total
of 42 patients with hepatocellular carcinoma (HCC) and 14 patients with colorectal
liver metastases (CLM) underwent laparoscopic liver resection in our surgical unit.
The choice of conventional total laparoscopic liver resection, hand-assisted
laparoscopic liver resection or robot-assisted laparoscopic liver resection was
determined by the surgeon’s preference. With the introduction of robotic system,
almost all those suitable tumors for laparoscopic resection were performed by
robot-assisted approach.
All patients had a chest X-ray, ultrasonography (USG) of abdomen, contrast
computed tomography (CT) scan of abdomen and/or positron emission tomography
(PET) scan. Laboratory blood tests including hepatitis B surface antigen, antibodies
to hepatitis C, serum alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA),
serum albumin, total bilirubin, aspartate aminotransferase, alanine aminotrans-
ferase and prothrombin time were obtained and the Pugh’s modiﬁcation of Child’s
criteria was determined. Further investigations were performed only when there
was clinical suspicious of extrahepatic metastases. Radiologic studies were reviewed
in a multidisciplinary case management meeting held weekly.
The selection criteria included normal liver or Child’s A cirrhosis, tumor size less
or equal to 5 cm, and tumor located at anterio-inferio-lateral segments (Couinaud
segments 2, 3, 4b, 5, 6) for laparoscopic resection. Solitary exophytic tumor > 5 cm
accessible to the laparoscopic approach was considered also. All procedures were
performed by consultant surgeons with expert in hepatobiliary and laparoscopic
surgery after obtaining informed consent. After operation, all patients were followed
up with serial AFP, or CEA assay, and USG or CT scan of the abdomenwas performed
every 3e6 months.
2.1. Operative procedure of laparoscopic liver resection
The patient was placed in Lloyd-Davis position. The chief surgeon operated
between patient’s legs with assistants on each side. Preoperative laparoscopic
staging was performed ﬁrst before liver resection. A sub-umbilical open technique
was used to insert a 10 mm port, and pneumoperitoneum was established with
carbon dioxide insufﬂation to a maximum pressure of 12 mmHg. Using a 30
laparoscope, the liver surface, porta hepatic and peritoneal surfacewere inspected. A
second access port was inserted in the right upper quadrant at the mid-clavicular
line under video guidance. The laparoscopic USG (7.5 MHz; Aloka, Wallingford,
Connecticut) was inserted through this port and was placed in contact with the liver
and the porta hepatis. Apart from the preoperative staging and assessment of liver
functional reserve, the subsequent plane of transection could then be easily deter-
mined. The planned transection planewasmarked on the liver surface by diathermy.
The conventional total laparoscopic liver resection was performed with a 10-
mm camera port, one 12-mm operative port and two/three 5-mm operative ports.
The da Vinci S Surgical System (Intuitive Surgical Inc., Sunnyvale, CA) was used for
all robot-assisted procedures. A 12-mm camera port, 12-mm operative port, and
threeworking 8-mm robotic ports were utilized. The trocar insertion sites depended
on the location of the hepatic lesion. For hand-assisted laparoscopic liver resection,
the position of Gelport (Applied Medical Resources Corp, Rancho Santa Margarita,
California) was governed by the position of patient and the type of liver resection. A
7-cm long transverse incision (based on the palm size of the operating surgeon) was
made at the right side of abdomen, slightly above the level of the umbilicus. The
incision should not be directly over the pathology or too close to the laparoscope,
otherwise the visual ﬁeld and the range of movement would be very limited. One
12-mm operative port and two/three 5-mm operative ports were used. The surgical
technique was as follows. The ligaments attaching the liver were divided, e.g. left
triangular ligament for left lateral sectionectomy and right triangular ligament for
right liver pathology. The falciform ligament was routinely transectedwith the aid of
LigaSure (Valleylab, Boulder, Colorado)) and the stump was grasped for retraction.
For selected patients with good liver functional reserve, Pringle maneuver was used
to apply intermittent vascular control to reduce blood loss. To accomplish this, the
a vascular lesser omentum was divided and a vascular sling was passed around the
hepatoduodenal ligament. If vascular control was required, the tension could be
tightened and retained as needed. After these preliminary steps and provided the
central venous pressure was optimal (<5 cm H2O), parenchymal resection was
carried out using a Harmonic Scalpel (UltraCision; Ethicon, Cincinnati, Ohio) andultrasonic surgical aspirator (Sonopet UST2000; M&M Co Ltd, Tokyo, Japan). Minor
vessels and bile ducts were controlled with bipolar scissors. Application of either
a titanium clip or endostapler was used for the main vascular branches and bile
ducts. At the completion of the parenchymal transection, the raw surface was
inspected for any bile leak or oozing and such areas were plicated with 2/0 poly-
propylene. An argon beam coagulator was also used to achieve hemostasis from any
oozing surface. During the use of argon beam coagulator, surgeons and anesthetists
should be aware that there is a potential to develop a gas embolism and that
adequate precautions should be taken to prevent this such as selecting a low ﬂow
setting on the argon beam coagulator and adequate venting of the abdomen through
chimneys in laparoscopic ports to maintain safe pressures of between 8 and
12 mmHg. All specimens were retrieved inside a protective bag.
2.2. Statistical method
Prospectively collected data, including intraoperative parameters, post-opera-
tive complications, hospital mortality, and disease progress, were analyzed. Overall
survival and disease-free survival were measured from the date of operation to the
time of death and to the time when recurrent tumor was ﬁrst diagnosed, respec-
tively. Survival analysis was estimated by the KaplaneMeier survival method.
3. Results
During the study period, a total of 56 patients with hepatic
malignancies (HCC, n ¼ 42; CLM, n ¼ 14) underwent laparoscopic
liver resection in our surgical unit. These 56 resections were carried
out on 39 male and 17 female patients with median age of 60 years
old (rang, 35-82). Three resections were carried for the indication of
recurrent HCC. The demographic data and preoperative status of the
56 patients were shown in Table 1 and Table 2. The median preop-
erative AFP level was 9.1 (range, 1.7e112290) ng/mL. The median
preoperative CEA level was 7.5 (range, 1e92.8) ng/mL. The median
follow-up period was 16.9 months (range, 1e142.5 months).
3.1. Intraoperative results
Surgical procedures and operative details were shown in Tables
3 and 4. The majority of cases were performed by hand-assisted
laparoscopic approach, n¼ 31 (55.3%) and the remainder werewith
total laparoscopic approach, n ¼ 10 (17.9%) and robot-assisted
laparoscopic approach, n ¼ 15 (26.8%). The median operation time
was 150 min (range, 75e307 min). Only 2 major hepatectomy
(3.6%) was performed. The rest of hepatectomy was minor resec-
tion. The median blood loss during surgery was 175 ml (range,
5e2000 ml). Only 6 patients (10.7%) needed post-operative blood
transfusion. Two procedures (3.6%) need to be converted to open
approach and one procedure (1.8%) needed to be converted to
hand-assisted laparoscopic approach. One patient in the conven-
tional total laparoscopic group underwent left lateral sectionec-
tomy for HCC needed open conversion because of injury to the
branch of left hepatic vein, which resulted in moderate bleeding,
and the patient underwent immediate hemostasis and liver
resection. The other patient in conventional total laparoscopic
Table 2
Characteristics of the 14 patients with CLM.
Sex ratio (M:F) 8:6
Age [mean  SD] 68.2  9.5
Liver status
Liver cirrhosis (n) 0
Non-cirrhotic liver (n) 14
Synchronous diseases (n) 5
Metachronous diseases (n) 9
Primary cancer location (n)
rectum 6 (42.8%)
sigmoid 2 (14.3%)
recto-sigmoid junction 2 (14.3%)
right colon 4 (28.6%)
Previous open surgery for primary
cancer (n)
4
Previous laparoscopic surgery for primary
cancer (n)
7
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needed open conversion to release the pneumoperitoneum since
he had intraoperative marginal oxygen saturation caused by lobar
lung collapse and atelectasis. One patient in the robot-assisted
laparoscopic group underwent non-anatomical wedge resection for
HCC needed to convert to hand-assisted laparoscopic approach
because of injury to the branch of right hepatic vein, which resulted
in moderate bleeding, and the patient underwent immediate
hemostasis and liver resection.
3.2. Postoperative results
Pathology and post-operative outcome were shown in Tables 3
and 4. 89.3% of patients had R0 resection and 10.7% of patients
had R1 resection. The median hospital stay was 6.5 days (range,
2e13 days). There was no in-hospital death after operation. TheTable 3
Tumor characteristics and operative outcome for HCC.
Variables Hand-assisted
laparoscopic approach (n ¼








Segment V, VI 1
Hepatocellular carcinoma (HCC) 21
Combined hepatocellular-cholangiocarcinoma 2
Main tumor with satellite nodules 4
Type of liver resection
Wedge resection 9
Segmentectomy 7





Operating time (minutes) [mean  SD] 152.8  32.0
Median blood loss (ml) [median(range)] 150 (80e210)
Pringle maneuver used (n) 18
Time of vascular clamping (minutes) [mean  SD] 29  12.3
Convert to open approach 0





Post-operative hospital stay (days) [mean  SD] 7.1  2.0morbidity rate was 14.3%. Postoperative complications consisted of
post-operative hemorrhage (n ¼ 1), acute pulmonary oedema
(n ¼ 2), bile leakage with intra-abdominal abscess (n ¼ 1), and
wound infection (n ¼ 4). The patient with post-operative hemor-
rhage needed relaparotomy for hemostasis. None of the patients
developed liver failure, or encephalopathy. One patient was found
to have a port site incisional hernia during follow-up.3.3. Survival and recurrence for HCC
Sixteen (41%) of the 39 patients who were diagnosed for the ﬁrst
time as having HCC, developed disease recurrence (isolated intra-
hepatic recurrence, n ¼ 13; intra-hepatic recurrence and distant
metastases, n ¼ 2; and distant metastases only, n ¼ 1). For the 3
patients with laparoscopic liver resection for recurrent HCC, only one
patient had intra-hepatic disease recurrence at 17 months after
surgery. No patients developed tumor recurrence over the liver tran-
section region. No port site or peritoneal metastases was observed in
all thepatients.Themeantime intervalof recurrencewas18.4months.
76.5% of the recurrence occurred in the ﬁrst two-year after surgery.
The 1-year, 3-year, and 5-year disease-free survival rates were
85%, 47%, and 38%, respectively. The 1-year, 3-year, and 5-year
overall survival rates were 96%, 67%, and 52%, respectively.3.4. Survival and recurrence for CLM
Two patients had extrahepatic metastases and one patient had
both intra-hepatic and extrahepatic metastases. The mean interval
of recurrence was 8 months time. No port site or peritoneal
metastases was observed in all the patients.
The 1-year, and 3-year disease-free survival rates were 92% and
72%. The 1-year, and 3-year overall were 100% and 88%, respectively.23)
Conventional total
laparoscopic approach (n ¼ 10)
Robot-assisted
laparoscopic approach (n ¼ 9)

















97.7  27.4 198  48.5
80 (5e2000) 100 (20e1000)
2 6






7.7  3.6 6.0  1.9
Table 4
















3.2  2.2 2 3.3  1.6
Location of tumor(n)
Segment II 2 0 2
Segment III 2 0 0
Segment II, III 1 0 0
Segment IVb 0 0 1
Segment V 0 0 1
Segment VI 1 0 1
Segment V, VI 0 1 1
Segment VI, VII 1 0 0
Type of liver resection
Wedge resection 2 1 3










R0 resection 5 1 5
R1 resection 2 0 1
Operating time (minutes)
[mean  SD]
142.9  53.6 75 190.2  91.6
Median blood loss (ml)
[median(range)]




















8.4  3.2 6 6.8  2.8
E.C.H. Lai et al. / International Journal of Surgery 9 (2011) 324e328 327
ORIGINAL RESEARCH4. Discussion
The ﬁrst consensus meeting on laparoscopic liver surgery was
held in Louisville, Kentucky, in November 2008, incorporating the
opinions of the world’s experts in laparoscopic and open liver
surgery.2 The organizing committee selected 45 recognized experts
fromaround theworldwith themost extensive publishedexperience
in both laparoscopic and open liver surgery. They concluded that
laparoscopic liver surgery is a safe and effective approach to the
management of surgical liver disease in the hands of trained
surgeons with experience in hepatobiliary and laparoscopic surgery.
Currently acceptable indications for laparoscopic liver resection are
patientswith solitary lesions, 5 cmor less, located in liver segments 2
to 6. The laparoscopic approach to left lateral sectionectomy should
be considered standard practice. Nguyen et al. reviewed a total of 127
published articles of original series on laparoscopic liver resection
with2804 reportedminimally invasive liver resections.3 Fifty percent
were formalignant tumors, 45%were for benign lesions,1.7%were for
live donor hepatectomies, and the restwere indeterminate. Themost
common laparoscopic liver resection was a wedge resection or seg-
mentectomy (45%), followed by anatomic left lateral sectionectomy
(20%), right hepatectomy (9%), and left hepatectomy (7%). Conversionfrom laparoscopy to open laparotomyand from laparoscopy to hand-
assisted approach occurred in 4.1% and 0.7% of reported cases,
respectively. Overall mortality was 0.3%, and morbidity was 10.5%,
with no intraoperative deaths reported. The results of our cohort
were comparablewith international results. However, there was one
major limitation of our cohort series. There was only 2 major hepa-
tectomy in our series. Hence, more experience in major laparoscopic
liver resection has to be demonstrated in order to maintain accuracy
comparing our own results to the existed literature data.
Laparoscopic liver resection of HCC has not gained wide accep-
tance before and was a subject of controversy among liver surgeons.
Difﬁcult learning curves, adequate resectionmargins, tumor seeding,
metastases of thewounds, and the long-term outcome are themajor
concerns in laparoscopic surgery for HCC. No prospective, random-
ized controlled trials have been established to compare laparoscopic
with open liver resections for HCC. Several studies, however, have
retrospectivelycompared laparoscopicwithopen liver resection.10e15
Many groups have shown decreased blood loss, less pain medication
requirement, and shorter length of hospital stay with laparoscopic
versus open liver resection. In comparative studies, there were no
differences in margin-free resections and survival outcome between
laparoscopicandopen liver resection. Inaddition,no incidenceofport
site recurrence or tumor seeding has been reported. However, long-
termoutcomedataof laparoscopic liver resection forHCCwas limited
still in the literature. The5-year overall anddisease-free survival rates
after laparoscopic liver resection for HCC were 50%e81% and 24%e
45.6%, respectively.10e17 Our cohort study showed favorable survival
outcome also. The 1-year, 3-year, and 5-year disease-free survival
rates were 85%, 47%, and 38%, respectively. The 1-year, 3-year, and 5-
year overall survival rates were 96%, 67%, and 52%, respectively.
Laparoscopic liver resection for CLM has same challenges as
HCC. Survival outcome data of laparoscopic liver resection for CLM
was even scarcer in the literature. Nguyen et al. reported a multi-
institutional, international cohort study on laparoscopic liver
resection for CLM in 109 patients.18 The majority of patients
underwent prior abdominal operations (95%). Minimally invasive
approaches included totally laparoscopic (56%) and hand-assisted
laparoscopic (41%). There were 4 conversions to open surgery
(3.7%), all due to bleeding. Actuarial overall survivals at 1-, 3-, and
5-year for the entire series were 88%, 69%, and 50%, respectively.
Disease-free survivals at 1-, 3-, and 5-year were 65%, 43%, and 43%,
respectively. To date, no prospective randomized control trial has
been performed to compare survival between laparoscopic and
open hepatic resections. The only nonrandomized comparative
study of laparoscopic and open hepatectomy for CLM was per-
formed by Castaing et al.19 They compared two groups (60 patients
each) from two highly specialized liver surgery centers in France.
First, the laparoscopic group had a greater R0 resection rate than
the open group (87% vs. 72%). Second, the two groups had
comparable overall survival, with 1-, 3-, and 5-year rates of 97%,
82%, and 64% in the laparoscopic group, and 97%, 70%, and 56% in
the open group. Third, disease-free survival was comparable
between the two groups with 1-, 3-, 5-year rates of 70%, 47%, and
35% in the laparoscopic group and 70%, 40%, and 27% in the open
group. A limitation of this study is that the open hepatic resections
were performed in a large volume hepatobiliary center, whereas
the laparoscopic approach was performed by a single master
minimally invasive surgery surgeon. It is unclear whether or not
these results can be generalized or reproducible. Our cohort study
showed favorable survival outcome also. The 1-year, and 3-year
overall were 100% and 88%, respectively. The 1-year, and 3-year
disease-free survival rates were 92% and 72%, respectively.
Traditionally, laparoscopic liver resection can be performedwith
total laparoscopic approach or hand-assisted laparoscopic
approach. Techniques of hand-assisted laparoscopic has been
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laparoscopic approach. In our study, the choice of conventional
total laparoscopic liver resection, hand-assisted laparoscopic liver
resection or robot-assisted laparoscopic liver resection was deter-
mined by the surgeon’s preference. Initially, hand-assisted
approach was introduced ﬁrst and then followed by conventional
laparoscopic approach. With the introduction of robotic system,
almost all those suitable tumors for laparoscopic resection were
performed by robot-assisted approach. In our study, we tended to
use hand-assisted approach for those patients with larger tumor
size and more cirrhotic liver. During the whole study period, the
number of complications and R0 resection rate were almost evenly
distributed in the each quadrant of the study period. This
phenomenonmay be explained by that 1) we only selected suitable
cases for laparoscopic operation; and 2) all the operations were
performed by experienced laparoscopic and liver surgeons. Obvi-
ously, total laparoscopic procedure is superior to hand-assisted
approach in terms of wound pain, and cosmetic outcome as hand-
assisted laparoscopic liver resection usually required a 6e8 cm
incision for the placement of the hand-port. Another possible
disadvantage of hand-assisted laparoscopic approach includes
possible obstruction of the visual ﬁeld by the surgeon’s hand during
the operation. By making the appropriate incision and port sites,
one can minimize the possible disadvantage of obstruction of the
visual ﬁeld by the surgeon’s hand. This wide incision can also be
used as awindow for the delivery of liver specimens. The beneﬁts of
hand-assisted laparoscopic approach in hepatectomy are: (1)
facilitation in manual retraction, which may be the best atraumatic
tool; (2) feasibility in assessing margins of resectionwith the use of
tactile sensation; (3) safety in parenchymal dissection lapa-
roscopically; and (4) possibility of immediate hemostasis and
prevents air embolism in case the hepatic vein is severed.
The recent introduction of robotic surgical systems has revolu-
tionized the ﬁeld of minimally invasive surgery. It was developed to
overcome the disadvantages of conventional laparoscopic surgery.
Well-known advantages of the robotic system such as improved
vision via 3-dimensional view, magniﬁcation, tremor suppression,
and theﬂexibility of the instruments have allowedprecise operating
techniques in a variety of procedures in general surgery. The main
drawback of advanced robotic surgery is the associated cost. At the
current stage of development, the beneﬁts of robot-assisted surgery
in liver surgery have not yet been deﬁned. Only a few case reports or
series reporting the technique of robotic-assisted laparoscopic liver
resection were available in the literature.20e23 Our results are too
preliminary for a meaningful statistical analysis. Since all the liver
resection in this study didn’t involve biliary-enteric anastomosis
and porta hilar dissection, these potential advantages of robotic
system was not shown in this study. However, we noted that the
surgeons sitting in the console were more comfortable during the
operation and the dexterity of the instruments may shorten the
learning curve of attaining the skills. Of course, all these potential
advantages need larger scale of study to validate.
In conclusion, multimodality approach of laparoscopic liver
resection of hepatic malignancies was feasible, and safe in selected
patients. It is associated with a low complications rate. The survival
outcome was favorable also. However, the procedure should be per-
formed by surgical team expert in hepatobiliary and laparoscopic
surgery in properly selected patients. These favorable ﬁndings of
multimodality approach of laparoscopic resection for hepatic malig-
nancies need further investigation in larger scale of comparative
studies. It is still tooearly to concludewhich techniqueof laparoscopic
liver resection is better.
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